The U.S. Department of Veterans Affairs is testing the use of psychedelics to treat post-traumatic stress disorder in veterans. Ernesto Londoño, New York Times staff writer, discusses the thinking behind how and why it might work, and why this shift in how these drugs are viewed is happening now.